Qualify the buyer’s funding path as a set of checkable conditions, not as a statement that investors are interested. Ask who is expected to provide capital, what has been reviewed, which document records the interest, whether the document is binding, what conditions remain, and when funds could be available. Separate an investor conversation, indication, term sheet, approval, commitment, and closing-ready funds. Then compare the milestones with your sale timetable and require a credible fallback if a condition fails. Keep sensitive information limited until the buyer demonstrates progress, and have qualified legal, tax, and financial advisers review agreement-specific questions. The goal is not to reject every conditional buyer. It is to price process risk honestly and avoid treating hoped-for funding as available cash.
Start with the full funding chain
A buyer whose purchase depends on outside investors has a funding chain with several links: the buyer’s own contribution, equity or other capital from investors, debt if any, and the conditions that allow each source to be used. The first question is not “Do you have the money?” It is “What is the proposed source of every part of the purchase funding, and where is each source in its approval process?” FTC guidance for Commission-ordered divestitures illustrates this discipline by asking buyers to explain funding structure and limitations, identify all financing sources including private equity or other investors, and provide supporting plans. That guidance is specific to that process, not a universal rule for private sales, but the underlying diligence question is useful. [2]
Request a simple sources-and-uses summary at the level needed to evaluate feasibility. It should identify purchase consideration, expected transaction expenses, required working capital, and each funding source without asking for unnecessary personal financial details. Ask the buyer to label each source as available, expected, conditional, or still being raised. A range can be more honest than false precision when the amount is not final. The buyer should also identify what happens if the source is smaller, slower, or withdrawn.
Treat the summary as a working record, not proof. The proof is the underlying evidence, subject to confidentiality and appropriate review. A seller can ask for a redacted letter, investor communication, approved financing summary, or confirmation from an authorized representative, while allowing sensitive terms to remain hidden until a later stage. Counsel can help define what may be requested and shared in the relevant jurisdiction.
Distinguish interest from commitment
Outside-investor language often compresses different events into one phrase. “Investors are interested” may mean an introductory call. “Committed” may refer to a signed agreement, a conditional approval, or an internal expectation that still depends on diligence. Ask the buyer to name the document and its status. Useful categories include outreach, diligence underway, soft indication, term sheet, investment committee approval, signed commitment, funded escrow, and cash available to close. The labels are not legal conclusions. They are process labels that make remaining uncertainty visible.
The distinction matters because a document can look formal while leaving major conditions unresolved. The FDIC’s published financing terms say the document is a summary of basic business terms and does not constitute a commitment to lend. It also describes final transaction documents and conditions precedent. The document is for a specific FDIC financing context, so it does not define every lender’s practice. It does show why a seller should read operative language rather than infer certainty from a heading or logo. [3]
Ask for the exact statement that describes whether the capital provider is obligated, what can terminate or reduce the obligation, and whether the obligation covers this transaction. If the buyer cannot share the document, ask for a written summary of its status and conditions from an authorized person, then record the limitation. Do not call a nonbinding document a commitment in internal notes or seller communications.
Test the investor relationship and decision path
The investor relationship should be more than a name in a spreadsheet. Ask how the buyer knows the investor, whether the investor has reviewed the target’s materials, who makes the investment decision, and what event moves the investor from discussion to approval. If the investor is a fund or entity, ask which authorized body or person must approve the investment. If the capital is from individuals, ask the buyer to explain how the group will coordinate decisions and documentation without disclosing unnecessary personal data.
The SEC’s investor bulletin on private placements emphasizes that investors may receive limited disclosure and should obtain information needed for an informed decision. Its checklist points to financial information, management background, use of proceeds, and the reasonableness of claims. Those points support a practical seller test: has the outside investor actually received and reviewed the information needed to decide, or is the buyer describing a future fundraising effort? The bulletin concerns securities offerings and is not a rule governing an acquisition seller, so use it as a caution about evidence quality rather than as transaction advice. [1]
Look for a traceable decision path. The buyer should be able to state what has been reviewed, what questions remain, when the decision is expected, and what would cause a no. A vague promise to bring in capital is not a milestone. A dated diligence request, identified approval meeting, or signed conditional document is more useful because it creates a checkable next step.
Map conditions before sharing more access
Funding conditions may include satisfactory financial diligence, confirmatory legal review, an agreed purchase agreement, valuation or price limits, investor eligibility, lender approval, third-party consents, or a minimum equity contribution. Ask the buyer to list conditions in plain language and identify which party controls each one. A condition controlled by an outside investor is different from a condition controlled by the buyer, and both differ from a condition that depends on the seller or a third party.
For each condition, record four fields: evidence already received, next action, accountable owner, and effect if it fails. This turns a financing contingency into a workflow rather than a label. It also helps you decide what information is proportionate to release. If an investor has not reviewed a particular financial schedule, do not assume the capital is ready because the buyer has reviewed it.
Keep legal interpretation separate from process tracking. Whether a clause creates a financing contingency, termination right, deposit obligation, or another remedy depends on governing documents and applicable law. A qualified lawyer should review the purchase agreement and any confidentiality, securities, tax, or financing questions for the actual transaction.
Measure timing exposure against your process
A funding path can be credible and still be too slow for your sale process. Build a timeline from the next disclosure through diligence, investor approval, documentation, funding, and closing. Put an owner and date beside each milestone. Then identify the point at which you would need to pause, seek another buyer, revise the timetable, or require stronger evidence. The objective is not to manufacture urgency. It is to prevent an open-ended process from consuming attention while capital remains uncertain.
Ask what can happen in parallel and what must happen in sequence. The buyer may prepare documentation while an investor completes diligence, but the investor may not approve funds until the purchase agreement is settled. Record those dependencies rather than treating every date as independent. Also ask whether the investor’s indication expires, can be withdrawn, or changes if price, structure, or business performance changes.
Use stopping conditions that are observable. Examples include no evidence of investor review by an agreed checkpoint, a missed approval meeting with no replacement date, a material change in the funding source, or a condition that remains unexplained. These are process controls, not predictions about whether the buyer will close.
Request a fallback, not a reassurance
A serious buyer should explain what happens if the primary outside investor does not fund the expected amount. The fallback might be a different investor, a lower purchase price, more buyer equity, a different financing structure, or a decision not to proceed. You do not need to endorse the fallback. You need to know whether one exists and whether it creates new diligence, timing, confidentiality, or execution risks.
Evaluate the fallback using the same questions as the primary path: source, status, decision-maker, conditions, timing, and evidence. Do not count the same capital twice across multiple possible investors. Do not treat a broad list of prospects as a committed reserve. If the buyer cannot identify a workable fallback, keep the process conditional and limit costly next steps until funding evidence improves.
The seller should also decide its own boundary. You may continue exploratory discussions, but reserve deeper access, exclusivity, expense commitments, or a hard closing timetable for milestones that fit your risk tolerance and transaction documents. Get professional advice before setting terms that could have legal or tax consequences.
Use a controlled review workflow
A practical workflow has one source-of-truth funding record, one accountable human reviewer on the seller side, and a clear permission rule for each document. Store the buyer’s stated source, evidence date, status, conditions, next milestone, and reviewer notes together. Check that names, entities, amounts or ranges, dates, and transaction description match across the buyer’s summary and supporting materials. Flag contradictions instead of silently correcting them.
If software or AI helps organize the record, assign a human to verify every extracted field against the source document. The system should not contact investors, negotiate terms, approve disclosure, or decide that funding is sufficient. Use a small pilot on non-sensitive or appropriately protected material, define a stopping condition for extraction errors or confidentiality concerns, and keep the original document available for review. Do not assume a tool makes investor information secure, privileged, accurate, or compliant.
At the end of each review, write a short decision note: what is evidenced, what is conditional, what remains unknown, what may be shared next, and what would stop the process. This makes the qualification decision explainable without overstating the buyer’s ability to close.
Make qualification a documented human decision
Qualification is a judgment about process risk, not a guarantee of closing. A buyer can provide genuine evidence and still face changed conditions, investor withdrawal, diligence findings, or timing problems. Conversely, an early-stage buyer may become financeable after completing the right milestones. Keep those possibilities separate from what is evidenced today.
Acquivo is a software platform that delivers the entire sell-side M&A process, valuation, marketing materials, buyer matching, and deal management, on one platform for business owners, M&A attorneys, and boutique investment banks. Acquivo gives business owners the entire sell-side process an investment bank would run, as software, with no success fee. It is user-operated software, so the owner or appointed professional remains responsible for reviewing buyer evidence, controlling permissions, and making process decisions.
Use the resulting record to decide whether to continue, pause, change the information boundary, or ask for professional review. The strongest qualification file does not claim certainty. It shows the funding path, evidence behind each link, conditions still open, timing risk, and the human decision that follows.
Key Points
- Ask for every funding source and label each one as available, expected, conditional, or still being raised.
- Distinguish an investor conversation, indication, term sheet, approval, commitment, and funds available to close.
- Record each condition, its accountable owner, next milestone, evidence, and consequence if it fails.
- Compare the funding timeline with your sale process and set observable stopping conditions.
- Require a fallback plan, but do not count the same potential capital twice.
- Keep a human reviewer responsible for source checks, permissions, confidentiality choices, and the final process decision.
Sources and references
Source retrieval dates record research access, not article publication. Read our editorial and date policy.
Choose your next step
Acquivo is user-operated software. Owners and their professionals remain responsible for decisions, communications, and professional review.
Educational information, not individual legal, tax, or investment advice. Consult qualified professionals for your circumstances. Acquivo provides software, not representation or negotiation on your behalf.